Athens - Delayed Quote EUR

Lavipharm S.A. (LAVI.AT)

0.7640
-0.0160
(-2.05%)
At close: June 13 at 5:11:57 PM GMT+3
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
50,929
50,929
39,057
39,724
37,638
Cost of Revenue
27,734
27,734
21,435
23,835
21,415
Gross Profit
23,196
23,196
17,622
15,889
16,223
Operating Expense
19,015
19,015
13,887
10,507
11,114
Operating Income
4,181
4,181
3,735
5,382
5,109
Net Non Operating Interest Income Expense
-1,997
-1,997
-1,611
-1,813
-1,894
Pretax Income
3,247
3,247
2,257
2,747
3,309
Tax Provision
1,251
1,251
1,308
1,019
1,211
Net Income Common Stockholders
1,871
1,871
834
1,723
2,094
Diluted NI Available to Com Stockholders
1,871
1,871
834
1,723
2,094
Basic EPS
0.01
--
0.04
0.10
0.12
Diluted EPS
0.01
--
0.04
0.10
0.12
Basic Average Shares
167,868
--
21,526
17,027
18,292.5060
Diluted Average Shares
168,205
--
21,526
17,027
18,292.5060
Total Operating Income as Reported
--
--
3,844
4,560
5,203
Total Expenses
46,749
46,749
35,322
34,342
32,529
Net Income from Continuing & Discontinued Operation
1,871
1,871
834
1,723
2,094
Normalized Income
1,677.1155
1,677.1155
934.2800
2,392.9381
2,065.4687
Interest Income
270
270
30
21
26
Interest Expense
2,267
2,267
1,641
1,834
1,920
Net Interest Income
-1,997
-1,997
-1,611
-1,813
-1,894
EBIT
5,514
5,514
3,898
4,581
5,229
EBITDA
9,867
9,867
5,603
6,231
6,798
Reconciled Cost of Revenue
27,734
27,734
21,435
23,835
21,415
Reconciled Depreciation
4,353
4,353
1,705
1,650
1,569
Net Income from Continuing Operation Net Minority Interest
1,998
1,998
953
1,723
2,094
Total Unusual Items Excluding Goodwill
522
522
24
-1,065
45
Total Unusual Items
522
522
24
-1,065
45
Normalized EBITDA
9,345
9,345
5,579
7,296
6,753
Tax Rate for Calcs
0.0004
0.0004
0.0002
0.0004
0.0004
Tax Effect of Unusual Items
201.1155
201.1155
5.2800
-395.0619
16.4687
12/31/2020 - 11/8/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade